(Q35862482)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15309891%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

title

Acute pancreatitis associated with interferon and ribavirin therapy in patients with chronic hepatitis C (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15309891%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

1 reference

1 reference

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15309891%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Steven Batash

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15309891%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

author name string

Swati Chaudhari

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15309891%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Bhupinderjit S Anand

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15309891%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Neville R Pimstone

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15309891%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Douglas T Dieterich

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15309891%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Edmund J Bini

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15309891%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

publication date

1 June 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15309891%20AND%20SRC:MED&resulttype=core&format=json

Digestive Diseases and Sciences

31 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15309891%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

volume

49

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15309891%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15309891%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

page(s)

1000-1006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15309891%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1023/b:ddas.0000034562.17003.50

31 December 2019

exact match

0 references

cites work

Hepatic failure and lactic acidosis due to fialuridine (FIAU), an investigational nucleoside analogue for chronic hepatitis B.

1 reference

12 December 2020

Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group

1 reference

12 December 2020

Tolerance and efficacy of oral ribavirin treatment of chronic hepatitis C: a multicenter trial.

1 reference

12 December 2020

Differential effects of nucleoside analogs on oxidative phosphorylation in human pancreatic cells

1 reference

12 December 2020

Acute pancreatitis associated with interferon alpha therapy for chronic myelogenous leukemia

1 reference

12 December 2020

Prolonged therapy of chronic hepatitis C with ribavirin

1 reference

12 December 2020

Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (I

1 reference

12 December 2020

Lipoprotein changes in patients with chronic hepatitis C treated with interferon-alpha.

1 reference

12 December 2020

Review article: drug-induced pancreatitis.

1 reference

12 December 2020

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

1 reference

12 December 2020

The prevalence of hepatitis C virus infection in the United States, 1988 through 1994

1 reference

12 December 2020

Premature discontinuation of interferon plus ribavirin for adverse effects: a multicentre survey in 'real world' patients with chronic hepatitis C.

1 reference

12 December 2020

Ribavirin treatment for patients with chronic hepatitis C: results of a placebo-controlled study

1 reference

12 December 2020

Ribavirin as therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial

1 reference

12 December 2020

Interferon alpha induces disorder of lipid metabolism by lowering postheparin lipases and cholesteryl ester transfer protein activities in patients with chronic hepatitis C

1 reference

12 December 2020

Therapy of hepatitis C: meta-analysis of interferon alfa-2b trials

1 reference

12 December 2020

Ribavirin--current status of a broad spectrum antiviral agent

1 reference

12 December 2020

Side effects of therapy for chronic hepatitis C.

1 reference

12 December 2020

A randomized, double-blind trial comparing pegylated interferon alfa-2b to interferon alfa-2b as initial treatment for chronic hepatitis C.

1 reference

12 December 2020

1 reference

12 December 2020

Drug-induced pancreatitis: a critical review

1 reference

12 December 2020

Efficacy of interferon treatment for patients with chronic hepatitis C: comparison of response in cirrhotics, fibrotics, or nonfibrotics

1 reference

12 December 2020

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

1 reference

12 December 2020

Acute pancreatitis attributed to the use of interferon alfa-2b.

1 reference

12 December 2020

Management of severe acute pancreatitis

1 reference

12 December 2020

Changes in serum lipoprotein profile during interferon therapy in chronic hepatitis C.

1 reference

12 December 2020

Intravenous ribavirin for hantavirus pulmonary syndrome: safety and tolerance during 1 year of open-label experience. Ribavirin Study Group.

1 reference

12 December 2020

Acute pancreatitis associated with interferon-alpha therapy for chronic myelogenous leukemia

1 reference

12 December 2020